Valuation (81%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 25.17 | N/A |
| PEG Ratio (TTM) | 0.32 | N/A |
| P/S Ratio (TTM) | 9.15 | N/A |
| P/B Ratio (TTM) | 0.83 | N/A |
| P/FCF Ratio (TTM) | 11.82 | N/A |
| Price to 5YR AVG Earnings Ratio | 24.47 | N/A |
| Price to 5YR AVG FCF Ratio | 14.04 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.02% | N/A |
| ROE (TTM) | 3.30% | N/A |
| Net Profit Margin (TTM) | 36.36% | N/A |
| ROIC 5YR AVG | 2.55% | N/A |
Growth (67%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 149.97% | 27.68% | -15.89% |
| Revenue | -7.08% | 33.48% | -4.01% |
| Net Income | 152.11% | 180.40% | 75.80% |
| Cash Flow | 112.01% | -131.34% | 95.77% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.07 | N/A |
| Quick Ratio (TTM) | 0.07 | N/A |
| D/E Ratio (TTM) | 0.61 | N/A |
| Interest Coverage (TTM) | 3.89 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.22 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | 70.12% | N/A |